President, Chief Medical Officer · Coya Therapeutics, Inc. (COYA)

Fred Grossman

A named executive officer of Coya Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,457,433

Salary $498,160Stock awards $0Bonus $288,933

FY2024: $1,892,438

3rd of 4 named executive officers at Coya Therapeutics by FY2025 total.

4 named officers on file for Coya Therapeutics, FY2025

Fred Grossman’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Coya Therapeutics’s whole pay program stands against its peers

  • Coya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on COYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 13, 2026 (DEF 14A).

Free

Get Fred Grossman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Fred Grossman compensation by year

Coya Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Coya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$227,000$479,000$498,160
Bonus$113,500$191,600$288,933
Stock awards$0$0$0
Option awards$251,982$1,221,838$670,340
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$0$0$0
Total$592,482$1,892,438$1,457,433

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coya Therapeutics, Inc. DEF 14A filed May 13, 2026, accession 0001193125-26-220688, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Coya Therapeutics, Inc. filed document, accession 0001193125-26-220688. Every figure is read from that document and cited to the page and table it appears in. Filed May 13, 2026.

$592K
$1.9M
$1.5M
FY23
FY24
FY25
SalaryBonusOption awards

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option33,337—$8.15
Option97,613—$6.07
Option14,403—$4.25
Option14,399—$5.90
Option29,546—$5.90

Per the Outstanding Equity Awards at Fiscal Year-End table in Coya Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Coya Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Arun SwaminathanChief Executive Officer, Director$2,091,007
Howard BermanFormer Chief Executive Officer, Former Executive Chairman of the Board$1,471,701
Fred Grossman · this pagePresident, Chief Medical Officer$1,457,433
David SnyderChief Financial Officer and Chief Operating Officer$1,368,700

The full Coya Therapeutics compensation record

free company brief

This page is one person within Coya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Coya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Fred Grossman's compensation dossier · One-time report. No refunds.